Sign In
Buy BPMC
$129.46
+0 (+0%)
At Close: Oct 17, 2025
Blueprint Medicines (NASDAQ:BPMC) Lifted to Hold at BidaskClub
05:22am, Monday, 23'rd Mar 2020
BidaskClub upgraded shares of Blueprint Medicines (NASDAQ:BPMC) from a sell rating to a hold rating in a research note published on Thursday morning, BidAskClub reports. A number of other equities ana
Blueprint Medicines Corp (NASDAQ:BPMC) Given Average Recommendation of "Buy" by Analysts
10:34am, Sunday, 22'nd Mar 2020
Blueprint Medicines Corp (NASDAQ:BPMC) has earned an average rating of “Buy” from the sixteen analysts that are currently covering the company, Marketbeat reports. One research analyst has rated t
Blueprint Medicines Corporation: An Undervalued Company With Attractive Prospects
07:11pm, Friday, 20'th Mar 2020
There have been multiple catalysts related to lead asset, avapritinib in 2020. The company also has other promising assets in its pipeline. Investors should con
Mar 20, 2020 (The Expresswire) --
Global “Gastrointestinal Stromal Tumor (GIST) Drug Market” Report 2020 is a comprehensive, professional report provides a...
